Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals

Madhav Thambisetty, Romina Tripaldi, Joanna Riddoch-Contreras, Abdul Hye, Yang An, James Campbell, Jitka Sojkova, Anna Kinsey, Steven Lynham, Yun Zhou, Luigi Ferrucci, Dean F. Wong, Simon Lovestone, Susan M. Resnick

Research output: Contribution to journalArticlepeer-review

63 Scopus citations


Blood-based markers reflecting core pathological features of Alzheimer's disease (AD) in pre-symptomatic individuals are likely to accelerate the development of disease-modifying treatments. Our aim was to discover plasma proteins associated with brain amyloid-β (Aβ) burden in non-demented older individuals. We performed discovery-phase experiments using two dimensional gel electrophoresis (2DGE) and mass spectrometry-based proteomic analysis of plasma in combination with 11C-PiB PET imaging of the brain in samples collected 10 years prior to the PET scans. Confirmatory studies used ELISA assays in a separate set of blood samples obtained within a year of the PET scans. We observed that a panel of 18 2DGE plasma protein spots effectively discriminated between individuals with high and low brain Aβ. Mass spectrometry identified these proteins, many of which have established roles in Aβ clearance, including a strong signal from apolipoprotein-E (ApoE). In validation-phase studies, we observed a strong association between plasma ApoE concentration and Aβ burden in the medial temporal lobe. Targeted voxel-based analysis localized this association to the hippocampus and entorhinal cortex. APOE ε4 carriers also showed greater Aβ levels in several brain regions relative to ε4 non-carriers. These results suggest that both peripheral concentration of ApoE protein and APOE genotype are related to early neuropathological changes in brain regions vulnerable to AD pathology even in the non-demented elderly. Our strategy combining proteomics with {\it in vivo} brain amyloid imaging holds promise for the discovery of biologically relevant peripheral markers in those at risk for AD.

Original languageEnglish
Pages (from-to)1099-1109
Number of pages11
JournalJournal of Alzheimer's Disease
Issue number4
StatePublished - 2010


  • Alzheimer's disease
  • amyloid-β
  • biomarker
  • brain
  • plasma
  • proteomics


Dive into the research topics of 'Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals'. Together they form a unique fingerprint.

Cite this